Lidocaine vaginal gel: Phase IIb expanded

Juniper increased enrollment to up to 185 patients from 150 in a double-blind, placebo-controlled, U.S. Phase IIb trial evaluating a single dose of 150 mg COL-1077. The trial is enrolling women underg...